Live Price Coverage: What’s Propelling Rockwell Medical Inc to Increase So Much?

Live Price Coverage: What's Propelling Rockwell Medical Inc to Increase So Much?

The stock of Rockwell Medical Inc (NASDAQ:RMTI) is a huge mover today! The stock increased 5.71% or $0.35 on November 23, hitting $6.48. About 322,099 shares traded hands. Rockwell Medical Inc (NASDAQ:RMTI) has declined 27.27% since April 22, 2016 and is downtrending. It has underperformed by 32.68% the S&P500.
The move comes after 5 months positive chart setup for the $312.01 million company. It was reported on Nov, 24 by Barchart.com. We have $7.00 PT which if reached, will make NASDAQ:RMTI worth $24.96M more.

Analysts await Rockwell Medical Inc (NASDAQ:RMTI) to report earnings on March, 6. They expect $-0.10 earnings per share, up 16.67% or $0.02 from last year’s $-0.12 per share. After $-0.09 actual earnings per share reported by Rockwell Medical Inc for the previous quarter, Wall Street now forecasts 11.11% negative EPS growth.

Rockwell Medical Inc (NASDAQ:RMTI) Ratings Coverage

Out of 2 analysts covering Rockwell Medical (NASDAQ:RMTI), 0 rate it a “Buy”, 2 “Sell”, while 0 “Hold”. This means 0 are positive. Rockwell Medical has been the topic of 5 analyst reports since August 6, 2015 according to StockzIntelligence Inc. Bank of America downgraded the stock to “Underperform” rating in Tuesday, November 8 report. The rating was upgraded by TheStreet on Thursday, August 13 to “Sell”. On Thursday, August 13 the stock rating was initiated by Morgan Stanley with “Underweight”. The company was maintained on Saturday, August 22 by Oppenheimer. On Thursday, August 6 the stock rating was maintained by Oppenheimer with “Outperform”.

According to Zacks Investment Research, “Rockwell Medical Technologies, Inc. manufactures hemodialysis concentrates and dialysis kits, and sells, distributes and delivers such concentrates and dialysis kits, as well as other ancillary hemodialysis products, to hemodialysis providers in the United States. Hemodialysis is a process which is able to duplicate kidney function in patients whose kidneys have failed to function properly.”

Insitutional Activity: The institutional sentiment decreased to 0.66 in 2016 Q2. Its down 0.24, from 0.9 in 2016Q1. The ratio fall, as 11 funds sold all Rockwell Medical Inc shares owned while 28 reduced positions. 9 funds bought stakes while 26 increased positions. They now own 10.76 million shares or 10.05% less from 11.96 million shares in 2016Q1.
The New Jersey-based Kcg Hldgs has invested 0% in Rockwell Medical Inc (NASDAQ:RMTI). Moreover, D E Shaw & Inc has 0% invested in Rockwell Medical Inc (NASDAQ:RMTI) for 127,364 shares. Synovus Fincl Corporation last reported 500 shares in the company. Tiaa Cref Inv Management Lc accumulated 144,518 shares or 0% of the stock. Jpmorgan Chase holds 0% or 31,369 shares in its portfolio. Cranbrook Wealth Limited Co has 0.01% invested in the company for 2,262 shares. Metropolitan Life Co New York has invested 0% of its portfolio in Rockwell Medical Inc (NASDAQ:RMTI). Gru One Trading L P accumulated 142,498 shares or 0.01% of the stock. Retail Bank Of Montreal Can reported 144,523 shares or 0% of all its holdings. The Ontario – Canada-based Manufacturers Life Ins The has invested 0% in Rockwell Medical Inc (NASDAQ:RMTI). Vanguard Gp has invested 0% of its portfolio in Rockwell Medical Inc (NASDAQ:RMTI). Barclays Public Ltd Company accumulated 17,100 shares or 0% of the stock. First Republic Inv Management has 14,306 shares for 0% of their US portfolio. Zurcher Kantonalbank (Zurich Cantonalbank) holds 0% or 1,547 shares in its portfolio. Swiss Bank & Trust owns 93,100 shares or 0% of their US portfolio.

Insider Transactions: Since August 12, 2016, the stock had 0 insider purchases, and 5 sales for $207,242 net activity. HOLT KENNETH L sold 2,533 shares worth $15,299.

More notable recent Rockwell Medical Inc (NASDAQ:RMTI) news were published by: Fool.com which released: “3 Predictions for Rockwell Medical Inc. in 2016” on December 10, 2015, also Fool.com with their article: “3 Ways Rockwell Medical Inc. Could Turn Things Around” published on October 07, 2016, Fool.com published: “Will Rockwell Medical Inc. Sink or Swim?” on April 06, 2016. More interesting news about Rockwell Medical Inc (NASDAQ:RMTI) were released by: Fool.com and their article: “Why Rockwell Medical, Inc. Shares Are Crashing Today” published on March 01, 2016 as well as Fool.com‘s news article titled: “Rockwell Medical Stock Upgraded: What You Need to Know” with publication date: August 19, 2016.

RMTI Company Profile

Rockwell Medical, Inc. (Rockwell), incorporated on October 25, 1996, is a biopharmaceutical firm targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with services and products for the treatment of iron deficiency, secondary hyperparathyroidism and hemodialysis. The Firm operates through the hemodialysis market segment, which involves the manufacture, sale and distribution of hemodialysis products to hemodialysis clinics, including pharmaceutical, dialysis concentrates, dialysis kits and other ancillary products used in the dialysis process. The Company’s lead branded drug, Triferic is indicated for iron maintenance.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Related posts

Leave a Comment